The pharmacological mechanisms of omalizumab in patients with very high IgE levels-Clues from studies on atopic dermatitis
Seventeen case series investigating the effects of omalizumab on patients with atopic dermatitis included patients whose pretreatment serum IgE was above 700 IU/ml, the upper inclusion limit specified in the product label. In all, 107 patients received omalizumab at doses of ≤375 mg every 2 weeks, w...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2012-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |